Quick Answer
VERACYTE, INC. reported Cash and Equivalents of $362.58 million for fiscal year 2025.
VERACYTE, INC. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $362.58M | +51.7% |
| 2024 | $239.09M | +10.5% |
| 2023 | $216.45M | +40.3% |
| 2022 | $154.25M | -10.9% |
| 2021 | $173.20M | -50.4% |
| 2020 | $349.36M | +119.3% |
| 2019 | $159.32M | +104.3% |
| 2018 | $78.00M | +130.1% |
| 2017 | $33.89M | -42.8% |
| 2016 | $59.22M | +51.5% |
| 2015 | $39.08M | +11.6% |
| 2014 | $35.01M | -50.8% |
| 2013 | $71.22M | +408.6% |
| 2012 | $14.00M | +85.1% |
| 2011 | $7.57M | +172.6% |
| 2010 | $2.77M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $315.57M | +15.1% | +43.8% |
| June 30, 2025 | $219.50M | -7.0% | +17.9% |
| March 31, 2025 | $186.12M | -11.0% | -22.2% |
| December 31, 2024 | $239.09M | +10.5% | -12.8% |
| September 30, 2024 | $274.08M | +35.4% | +16.2% |
| June 30, 2024 | $235.91M | +23.4% | +12.8% |
| March 31, 2024 | $209.19M | +17.6% | -3.4% |
| December 31, 2023 | $216.45M | +40.3% | +6.9% |
- VERACYTE, INC. showed an increase of +51.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2010–2025 period, VERACYTE, INC.’s cash and equivalents has grown by 12965.9% (from $2.77 million to $362.58 million).
- The most recent figure is from VERACYTE, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: